Notes: In SPAF II warfarin appeared to be more effective than
aspirin for prevention of ischemic stroke in both age groups;
however, most of this benefit was lost because of a higher
rate of intracranial hemorrhage in the warfarin groups, especially
in the group that was over 75 years of age. In addition, the
younger patients.
The information in this
web site is not a substitute for medical advice or treatment.
Consultation with your doctor or health care professional is recommended.
Stroke Education
